A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/13/2002	EP1256354A1 Methods for treating cancer
11/13/2002	EP1256352A2 Immunomodulatory peptides
11/13/2002	EP1255849A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255815A1 Porcine reproductive and respiratory syndrome virus and methods of use
11/13/2002	EP1255769A2 Universal procedure for refolding recombinant proteins
11/13/2002	EP1255765A1 Pharmaceutical compositions and methods for treating rheumatoid arthritis
11/13/2002	EP1255563A1 Composition of antigen and glycolipid adjuvant sublingual administration
11/13/2002	EP1255562A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens
11/13/2002	EP1255561A2 Proteosome influenza vaccine
11/13/2002	EP1255560A2 Cd40 ligand adjuvant for respiratory syncytial virus vaccine
11/13/2002	EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255554A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0836482B1 Subunit vaccine against flavivirus infection
11/13/2002	EP0738281B1 Peptides and their uses against psoriasis
11/13/2002	EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/13/2002	EP0671926B1 Immunomodulatory peptides
11/13/2002	EP0606452B1 Vector vaccines of recombinant feline herpesvirus
11/13/2002	EP0584284B9 Recombinant dna-derived cholera toxin subunit analogs
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379786A Modified peptides and peptidomimetics for use in immunotherapy
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379684A Treating prostate cancer with anti-ErbB2 antibodies
11/13/2002	CN1379683A 疫苗 Vaccine
11/13/2002	CN1379682A Use of outer membrane protein of enterobacterium associated with RSV immunogeni peptide for preparing vaccines for intranasal administration
11/13/2002	CN1379664A Activation and protection of cytotoxic lymphocytes using reactive oxygen metabolite inhibitor
11/13/2002	CN1379663A Vaccine composition and method of using same
11/13/2002	CN1379109A Adenovirus carrier for specifically killing primary liver cancer cells and its application
11/12/2002	US6479652 Oligonucleotide mediated nucleic acid recombination
11/12/2002	US6479642 Cortistatin: neuropeptides
11/12/2002	US6479641 Amino acid sequences for use in the detection and separation of preferential microorganism from samples
11/12/2002	US6479635 Receptor activator of NF-κB
11/12/2002	US6479512 Tyrosine kinase inhibitors
11/12/2002	US6479286 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating T cells
11/12/2002	US6479284 Humanized antibody and uses thereof
11/12/2002	US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002	US6479258 Non-stochastic generation of genetic vaccines
11/12/2002	US6479250 Eck receptor ligands
11/12/2002	US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002	US6479245 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
11/12/2002	US6479056 Live vaccine constituting minor risk for humans
11/12/2002	US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002	US6479047 Lymphotactin as an adjuvant
11/12/2002	CA2176738C Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002	CA2068083C Anti-bacterial compound
11/12/2002	CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/08/2002	CA2387391A1 Hu antigen-derived peptides and uses thereof
11/07/2002	WO2002088384A1 Screening method
11/07/2002	WO2002088380A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/07/2002	WO2002088375A2 Compositions and methods relating to breast specific genes and proteins
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088361A2 Haemophilus influenzae antigens
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088334A1 Chimeric immunoreceptor useful in treating human cancers
11/07/2002	WO2002088328A2 Method for generating highly active human dendritic cells from monocytes
11/07/2002	WO2002088319A2 Mini-adenoviral vector and methods of using same
11/07/2002	WO2002088304A2 Compositions and methods for suppressing immune responses
11/07/2002	WO2002088183A2 G-protein coupled receptor
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	WO2002088177A1 Erav diagnostics and vaccines
11/07/2002	WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002	WO2002087625A1 Composite oncolytic herpes virus vectors
11/07/2002	WO2002087615A1 Human polyclonal antibody compositions
11/07/2002	WO2002087614A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002	WO2002087613A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002	WO2002087612A2 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases
11/07/2002	WO2002087601A1 Pharmaceutical composition containing bulbophyllum
11/07/2002	WO2002087502A2 Antibodies abolish prion propagation and promote clearance of infectivity
11/07/2002	WO2002087494A2 Novel vaccine
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002087336A1 Foot and mouth disease virus vaccine
11/07/2002	WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002	WO2002066605A3 Compositions and methods relating to breast specific genes and proteins
11/07/2002	WO2002066503A3 H. influenzae antigen basb213
11/07/2002	WO2002040513A3 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein
11/07/2002	WO2002038733A3 A selectable genetic marker for use in pasteurellaceae species
11/07/2002	WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002	WO2002030967A3 Novel compounds
11/07/2002	WO2002030960A3 Polypeptide from haemophilus influenza
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2002016414A3 Composition for the elimination of autoreactive b-cells
11/07/2002	WO2002012899A3 Peptides presented by cells
11/07/2002	WO2001071352A3 Compositions associated with complex formation
11/07/2002	WO2001058480A9 Tubulin based vaccine against trypanosomiasis

1 ... 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 ... 1823